[1]杨崇明,吴文涛.深度镇静下肝癌微波消融术中镇静相关不良事件发生率及危险因素分析[J].介入放射学杂志,2023,32(12):1202-1206.
　YANG Chongming,WU Wentao..Incidence of sedation-related adverse events during microwave ablation of liver cancer under deep sedation and analysis of its risk factors[J].journal interventional radiology,2023,32(12):1202-1206.

点击复制

深度镇静下肝癌微波消融术中镇静相关不良事件发生率及危险因素分析()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］ Vietti Violi N， Duran R， Guiu B， et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease： a randomised controlled phase 2 trial［J］. Lancet Gastroenterol Hepatol， 2018， 3： 317- 325.
［2］ 刘 晟，周平盛，沈 强，等． 超声引导下微波消融术治疗特殊部位与非特殊部位单发肝细胞癌的疗效对比［J］． 介入放射学杂志， 2023， 32：36- 42．
［3］ Puijk RS， Ziedses des Plantes V， Nieuwenhuizen S， et al. Propofol compared to midazolam sedation and to general anesthesia for percutaneous microwave ablation in patients with hepatic malignancies： a single- center comparative analysis of three historical cohorts［J］. Cardiovasc Intervent Radiol， 2019， 42： 1597- 1608.
［4］ Shamim F， Asghar A， Tauheed S， et al. Radiofrequency ablation of hepatocellular carcinomas： a new spectrum of anesthetic experience at a tertiary care hospital in Pakistan［J］. Saudi J Anaesth， 2017， 11： 21- 25.
［5］ Park MJ， Kim YS， Rhim H， et al. Prospective analysis of the pattern and risk for severe vital sign changes during percutaneous radiofrequency ablation of the liver under opioid analgesia［J］. AJR Am J Roentgenol， 2010， 194： 799- 808.
［6］ Nakamura S， Nouso K， Onishi H， et al. Prevention of vagotonia and pain during radiofrequency ablation of liver tumors［J］. Hepatol Res， 2014， 44： 1367- 1370.
［7］ 黎国燕，陈昌浩，黄 磊，等． 患儿手术室外麻醉镇静相关不良事件分析［J］． 临床麻醉学杂志， 2023， 39：168- 172．
［8］ Wu WT， Jia ZY， Chen Y， et al. The safety and efficacy of oxycodone versus fentanyl in percutaneous microwave ablation of a liver tumour abutting the capsule［J］. Cardiovasc Intervent Radiol， 2019， 42： 87- 94.
［9］ Wu WT， Zhou WZ， Zu QQ， et al. Risk factor for vital signs elevation during percutaneous microwave ablation of liver tumor under deep sedation［J］. Jpn J Radiol， 2021， 39： 1196- 1205.
［10］ Jin Q， Chen X， Zheng S. The security rating on local ablation and interventional therapy for hepatocellular carcinoma（HCC） and the comparison among multiple anesthesia methods［J］. Anal Cell Pathol（Amst）， 2019， 2019： 2965173.
［11］ Fang C， Cortis K， Yusuf GT， et al. Complications from percutaneous microwave ablation of liver tumours： a pictorial review［J］. Br J Radiol， 2019， 92： 20180864.
［12］ van Schaik EPC， Blankman P， van Klei WA， et al. Hypoxemia during procedural sedation in adult patients： a retrospective observational study［J］. Can J Anaesth， 2021， 68： 1349- 1357.
［13］ Lee SH， Rhim H， Kim YS， et al. Percutaneous radiofrequency ablation of hepatocellular carcinomas： factors related to intrapro-cedural and postprocedural pain［J］. AJR Am J Roentgenol， 2009， 192： 1064- 1070.
［14］ Blackburn SC， Stanton MP. Anatomy and physiology of the peritoneum［J］. Semin Pediatr Surg， 2014， 23： 326- 330.
［15］ DiMarco AF. Diaphragm pacing［J］. Clin Chest Med， 2018， 39： 459- 471.
［16］ Brown R， Burton AR， Macefield VG. Autonomic dysreflexia： somatosympathetic and viscerosympathetic vasoconstrictor responses to innocuous and noxious sensory stimulation below lesion in human spinal cord injury［J］. Auton Neurosci， 2018， 209： 71- 78.
［17］ Gebhart GF， Bielefeldt K. Physiology of visceral pain［J］. Compr Physiol， 2016， 6： 1609- 1633.
［18］ Park SJ， Lee DH， Han JK. Reducing pain by artificial ascites infusion during radiofrequency ablation for subcapsular hepato-cellular carcinoma［J］. Cardiovasc Intervent Radiol， 2021， 44： 565- 573.
［19］ Onik O， Onik C， Medary I， et al. Life- threatening hypertensive crises in two patients undergoing hepatic radiofrequency ablation［J］. AJR Am J Roentgenol， 2003， 181： 495497.